Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Dr. Reddy's looks healthy amid slump in India stocks: cost-competitive pharmaceutical firm's shares might be right cure for investors, analysts say

Article Abstract:

Indian stock market observers unanimously rate the stocks of pharmaceutical firm Dr. Reddy's Laboratories Ltd. with a buy rating, due to the phenomenal gains of the company's shares. Dr. Reddy's shares are a few of the better-performing stocks in the Indian stock-exchange, with its stocks trading at about 19 times its forecast earnings for the year ending March 31, 1999. Dr. Reddy posted a 69% increase in net profits for in the first quarter ending June 30, 1998, with net profits amounting to 214 mil rupees and sales posting a 35% increase to reach 1.14 bil rupees. Dr. Reddy's is seen by many Indian stock market analysts as the safest place for investments, with the company's profits coming from its market of formulations and the company's investments in research and development.

Author: Sharma, Sumit
Publisher: Dow Jones & Company, Inc.
Publication Name: The Asian Wall Street Journal Weekly
Subject: Business, international
ISSN: 0191-0132
Year: 1998
Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Pharmaceutical industry, Stock-exchange, Stock exchanges, Dr. Reddy's Laboratories Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Indian fund industry is hurt by its image

Article Abstract:

The Securities and Exchange Board of India will introduce changes in mutual fund rules in Aug. 1996 amidst weakening investor confidence. A proposal grants greater flexibility to asset-management firms to launch specific-area investment funds. Other proposals include allowing fund managers freedom to invest in money-market instruments and government bonds and the increase in investment limits to a single firm from 5% to 10% of the fund's assets.

Author: Sharma, Sumit
Publisher: Dow Jones & Company, Inc.
Publication Name: The Asian Wall Street Journal Weekly
Subject: Business, international
ISSN: 0191-0132
Year: 1996
Investment Companies, Open-End Investment Funds, Laws, regulations and rules, India. Securities and Exchange Board of India

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Indian fund's redemptions may set tone for stock market

Article Abstract:

Unit Trust of India's Unit Scheme 1964 (US-64) has suffered a sharp depreciation and analysts are worried that investors may redeem their investments. Analysts are worried that wary investors may force the company to sell-off shares to finance redemptions and thus complicate the company's financial situation. Analysts worry also that the sharp decline could hold off the infusion of fresh capital into the company.

Author: Sharma, Sumit
Publisher: Dow Jones & Company, Inc.
Publication Name: The Asian Wall Street Journal Weekly
Subject: Business, international
ISSN: 0191-0132
Year: 1998
Mutual Fund Mgmt Companies, Portfolio Management, Finance, Unit Trust of India

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: India, Securities, Mutual funds
Similar abstracts:
  • Abstracts: Some pros hail a bargain after falls at Steady Safe. Buybacks in Japan decline: fall may bode ill for share prices, analysts say
  • Abstracts: Fund managers in Singapore fear CPF cut: drop in contribution levels could impact other investments, they say
  • Abstracts: Gitic's closure boosts fears. Gitic's liquidation process is foreign to many lenders: case is eye-opener for overseas creditors still in the dark about asset prices
  • Abstracts: A Heath Robinson constitution. New Lords for old. Federalism by stealth
  • Abstracts: A sorry lot of Democrats(poor candidates from Democratic party in governorship elections in mid-west) Out of shambles, stength?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.